BDX News and Press, Becton Dickinson and Company From 02/05/23

Summary DexCom is young, innovative, admired, and (consequently) highly valued. Embecta is old, lethargic, lacks coverage, and (consequently) lowly valued. Growth and value investors may find respective equities interesting. I use DXCM and EMBC as a lens to view developments in ...

Summary Becton, Dickinson and Company is a leading player in the medical technology and life sciences industries, with a focus on both inpatient and outpatient settings. Becton, Dickinson in fiscal Q1 2023 reported a 3% growth in revenue to $4.59 billion and exceeded EPS expectations ($...

BD Introduces High-Throughput Single-Cell Multiomics Platform to Expand Scope of Scientific Discovery PR Newswire New BD Rhapsody™ HT Xpress System and Other Innovations to be Unveiled at AGBT, Enhancing an End-To-End Single-Cell Multiomics Offering FRANKL...

Becton, Dickinson's ( NYSE: BDX ) Q4 2022 financial results, which saw a beat on the top and bottom lines and a 2023 guidance lift, was met with approval by Street analysts. Evercore ISI's Vijay Kumar, who has an outperform rating on the stock, boosted his price target to $2...

Becton, Dickinson and Company (BDX) Q1 2023 Earnings Conference Call February 2, 2023 8:00 AM ET Company Participants Francesca DeMartino – Senior Vice President and Head-Investor Relations Tom Polen – Chairman, Chief Executive Officer and President Chris...

The following slide deck was published by Becton, Dickinson and Company in conjunction with their 2023 Q1 earnings call. For further details see: Becton, Dickinson and Company 2023 Q1 - Results - Earnings Call Presentation

Becton, Dickinson press release ( NYSE: BDX ): Q1 Non-GAAP EPS of $2.98 beats by $0.30 . Revenue of $4.6B (-2.5% Y/Y) beats by $10M . Company raises full-year revenue and adjusted EPS guidance: The company now expects fiscal year 2023 revenues to be in the range of...

BD Reports First Quarter Fiscal 2023 Financial Results PR Newswire Execution of BD 2025 Strategy Delivering Consistent and Durable Performance Revenue of $4.6 billion decreased 2.8% as reported and increased 1.7% on a currency-neutral basis Revenue from bas...

Becton, Dickinson ( NYSE: BDX ) is scheduled to announce Q1 earnings results on Thursday, February 2nd, before market open. The consensus EPS Estimate is $2.68 (-26.4% Y/Y) and the consensus Revenue Estimate is $4.59B (-8.2% Y/Y). Over the last 2 years, BDX has beaten EPS es...

BD Named to Bloomberg Gender-Equality Index for 4th Consecutive Year PR Newswire Company's Ongoing Commitment to Advance Workplace Equality Shows Progress in Female Leadership and Talent Pipeline FRANKLIN LAKES, N.J. , Jan. 31, 2023 /PRNewswire/ -- BD...